1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Blood Brain Barrier Technologies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Blood Brain Barrier Technologies Market Regional Analysis
6.2 North America Blood Brain Barrier Technologies Market Revenue 2019-2028 (US$ Million)
6.3 North America Blood Brain Barrier Technologies Market Forecast Analysis
7. North America Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Bispecific Antibody RMT Approach
- 7.1.1 Overview
- 7.1.2 Bispecific Antibody RMT Approach: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Trojan Horse Approach
- 7.2.1 Overview
- 7.2.2 Trojan Horse Approach: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Increasing Permeability
- 7.3.1 Overview
- 7.3.2 Increasing Permeability: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Passive Diffusion
- 7.4.1 Overview
- 7.4.2 Passive Diffusion: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Other Non-Invasive BBB Technologies
- 7.5.1 Overview
- 7.5.2 Other Non-Invasive BBB Technologies: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Blood Brain Barrier Technologies Market Analysis – by Application
8.1 Alzheimer's Disease
- 8.1.1 Overview
- 8.1.2 Alzheimer's Disease: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Epilepsy
- 8.2.1 Overview
- 8.2.2 Epilepsy: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Parkinson's Disease
- 8.3.1 Overview
- 8.3.2 Parkinson's Disease: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Multiple Sclerosis
- 8.4.1 Overview
- 8.4.2 Multiple Sclerosis: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Hunter's Syndrome
- 8.5.1 Overview
- 8.5.2 Hunter's Syndrome: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Brain Cancer
- 8.6.1 Overview
- 8.6.2 Brain Cancer: North America Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Blood Brain Barrier Technologies Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Blood Brain Barrier Technologies Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 North America Blood Brain Barrier Technologies Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 US: North America Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.1.2 US: North America Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.2 Canada:
North America Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Canada: North America Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.2.2 Canada: North America Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.3 Mexico :
North America Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Mexico : North America Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.3.2 Mexico : North America Blood Brain Barrier Technologies Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Eli Lilly and Company
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pfizer, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fabre-Kramer Pharmaceuticals, Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Bioasis Technologies, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Blood Brain Barrier Technologies Market
